Male and Female Rats Showed Similar THC Withdrawal, with One Exception

When THC-dependent rats were given a withdrawal-precipitating drug, males and females showed broadly similar withdrawal signs, though females exhibited more retropulsion.

Marusich, Julie A et al.·Drug and alcohol dependence·2014·Preliminary EvidenceAnimal StudyAnimal Study
RTHC-00830Animal StudyPreliminary Evidence2014RETHINKTHC RESEARCH DATABASErethinkthc.com/research

Quick Facts

Study Type
Animal Study
Evidence
Preliminary Evidence
Sample
Not reported

What This Study Found

After 6.5 days of twice-daily THC administration (30 mg/kg), rats challenged with the CB1 antagonist rimonabant displayed a pronounced withdrawal syndrome spanning multiple domains. Somatic signs included paw tremors, head twitches, and retropulsion. Cognitive disruptions included lack of locomotor habituation and impaired prepulse inhibition. Affective changes included increased startle reactivity.

With the exception of increased retropulsion (backward walking) in female rats, sex differences were minimal. Both sexes showed comparable withdrawal severity across most measures.

During chronic THC dosing, both male and female rats experienced weight loss, and females showed disrupted estrous cycling. Spontaneous withdrawal (without rimonabant) produced only minimal overt signs, consistent with the pattern seen in human cannabis withdrawal.

Key Numbers

THC dose: 30 mg/kg twice daily for 6.5 days. Withdrawal was precipitated with rimonabant. Female rats showed more retropulsion than males. Both sexes showed disrupted prepulse inhibition and increased startle reactivity.

How They Did This

Adult male and female Sprague-Dawley rats received either 30 mg/kg THC or vehicle twice daily for 6.5 days. On day 7, rats were challenged with either vehicle or the CB1 antagonist rimonabant to precipitate withdrawal. Researchers assessed somatic signs (paw tremors, head twitches, retropulsion), cognitive measures (locomotor habituation, prepulse inhibition), and affective measures (startle reactivity).

Why This Research Matters

This was the first study to systematically examine THC dependence in both male and female adult rats. The finding that withdrawal extends beyond somatic signs into cognitive and affective domains mirrors what humans report and suggests animal models may be more useful for studying cannabis withdrawal than previously thought.

The Bigger Picture

While female rodents show enhanced sensitivity to acute THC effects, this study found that chronic THC exposure produces largely similar withdrawal profiles across sexes. The breadth of withdrawal signs observed, spanning somatic, cognitive, and affective domains, parallels the multi-dimensional withdrawal syndrome described in human cannabis users.

What This Study Doesn't Tell Us

This was an animal study, and rat withdrawal patterns may not fully translate to human experience. Withdrawal was precipitated by a CB1 antagonist rather than occurring spontaneously, which may produce a more intense and acute withdrawal profile than natural cessation. The THC doses used were high relative to typical human consumption.

Questions This Raises

  • ?Do the cognitive and affective components of withdrawal drive relapse more than somatic symptoms?
  • ?Would sex differences become more pronounced with different THC doses or longer exposure periods?
  • ?How do hormonal fluctuations interact with cannabinoid withdrawal?

Trust & Context

Key Stat:
First study of THC dependence in adult rats of both sexes
Evidence Grade:
This is an animal study providing preliminary evidence. Findings need human confirmation.
Study Age:
Published in 2014. Research on sex differences in cannabis effects and withdrawal has expanded substantially since.
Original Title:
Evaluation of sex differences in cannabinoid dependence.
Published In:
Drug and alcohol dependence, 137, 20-8 (2014)
Database ID:
RTHC-00830

Evidence Hierarchy

Meta-Analysis / Systematic Review
Randomized Controlled Trial
Cohort / Case-Control
Cross-Sectional / Observational
Case Report / Animal StudyOne case or non-human subjects
This study

Tests effects in animals (usually mice or rats), not humans.

What do these levels mean? →

Frequently Asked Questions

What is precipitated withdrawal?

Instead of waiting for THC to naturally leave the body, researchers administered rimonabant, a drug that blocks CB1 receptors and instantly removes cannabinoid signaling. This produces a rapid, measurable withdrawal syndrome useful for research, but more intense than natural withdrawal.

Why do sex differences in drug response matter?

Women and men can respond differently to the same drug in terms of effects, side effects, dependence development, and withdrawal. Understanding these differences helps develop more personalized treatment approaches.

Read More on RethinkTHC

Cite This Study

RTHC-00830·https://rethinkthc.com/research/RTHC-00830

APA

Marusich, Julie A; Lefever, Timothy W; Antonazzo, Kateland R; Craft, Rebecca M; Wiley, Jenny L. (2014). Evaluation of sex differences in cannabinoid dependence.. Drug and alcohol dependence, 137, 20-8. https://doi.org/10.1016/j.drugalcdep.2014.01.019

MLA

Marusich, Julie A, et al. "Evaluation of sex differences in cannabinoid dependence.." Drug and alcohol dependence, 2014. https://doi.org/10.1016/j.drugalcdep.2014.01.019

RethinkTHC

RethinkTHC Research Database. "Evaluation of sex differences in cannabinoid dependence." RTHC-00830. Retrieved from https://rethinkthc.com/research/marusich-2014-evaluation-of-sex-differences

Access the Original Study

Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.

This study breakdown was produced by the RethinkTHC research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.